However, our prior studies have shown that activated HSC in vitro engages full-length CCN2 or proteolytic fragments of CCN2 via integrins, heparin sulfate proteoglycans, and low-density lipoprotein-related protein [31,50] and similar mechanisms are likely in NASH in vivo. Here, CCN2 is linked to metabolic dysfunction-associated steatohepatitis.